Pioglitazone Tablet
Product Images NDC 68788-7511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68788-7511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)
The text describes a figure showing the mean change from baseline for HbAlc in a 26-week placebo-controlled dose-ranging study. The figure displays the observed values over time in weeks for three different dosages (15mg, 30mg, 45mg) and a control group.*
FDA Label Image

Pioglitazone Tablets 15mg (Pioglitazone Fig2)

Pioglitazone Tablets 15mg (Pioglitazone Fig2)
Brand name: Actos. Generic name: Pioglitazone Hydrochloride Tablets. Strength: 15 mg. Manufacturer: Rising Health, LLC. This medication is used to improve blood sugar control in individuals with type 2 diabetes. It is important to follow the cautionary measures stated as per federal laws. The package size, batch number, and expiry date are mentioned on the package. For further details, consult a healthcare professional.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.